Smead Capital Management
Smead Capital Management (Smead Capital Management, Inc.) reported 31 positions worth $4.71B as of September 30, 2026 (13F filed October 16, 2026). Largest holding: CVE (9.0%). Biggest move: reduce AMGN ($30.7M).
| # | Symbol | Company | Value ↓ | % Port. | Time Held | Shares | Est. Buy Price | Gain | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ▸ 1 | CVE | $421.8M | 8.96% | 5.8 Years | 13,568,058 | $18.25 | +54.7% | — | — | -9.2% | |
| ▸ 2 | MRK | $335.1M | 7.12% | >10 Years | 2,305,916 | $83.19* | +73.7% | — | — | -0.6% | |
| ▸ 3 | APA | $320.4M | 6.81% | 3.8 Years | 7,714,207 | $32.47 | +45.7% | — | — | +13.9% | |
| ▸ 4 | MAC | $252.6M | 5.37% | 7.3 Years | 11,298,361 | $15.37 | +61.9% | — | — | +11.3% | |
| ▸ 5 | SPG | $252.0M | 5.36% | 6.8 Years | 1,255,022 | $119.55 | +94.7% | — | — | +15.9% | |
| ▸ 6 | AMGN | $247.2M | 5.25% | >10 Years | 586,504 | $218.29* | +111.8% | — | — | +9.7% | |
| ▸ 7 | COP | $195.1M | 4.15% | 6 Years | 1,558,825 | $75.97 | +85.0% | — | — | +12.3% | |
| ▸ 8 | TGT | $193.3M | 4.11% | 9.5 Years | 1,233,410 | $128.03 | +25.2% | — | — | +2.3% | |
| ▸ 9 | DHI | $190.9M | 4.06% | 6.8 Years | 1,396,714 | $84.44 | +71.4% | — | — | +5.9% | |
| ▸ 10 | LEN | $186.4M | 3.96% | >10 Years | 2,284,725 | $80.52* | +4.1% | — | — | +2.7% |
Related managers
Five closest superinvestors by Jaccard overlap of tickers held in the latest quarter (computed nightly).
| Manager | Overlap | Shared holdings |
|---|---|---|
| Berkshire Hathaway (Warren Buffett) | 10.9% | LEN, OXY, NVR, AXP, BAC, DHI |
| Davis Selected Advisers (Chris Davis) | 6.8% | FITB, SPG, JPM, AXP, BAC, COP, MTB, UNH +1 |
| Dodge & Cox | 6.6% | HD, OXY, AMGN, JPM, AXP, BAC, MRK, TGT +3 |
| Capital Research Global Investors | 5.7% | HD, SPG, AMGN, NVR, JPM, MRK, DHI, COP +3 |
| Ruane, Cunniff & Goldfarb | 5.4% | CACC, AXP, UNH, ZTS |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does Smead Capital Management hold as of Q3 2026?
Smead Capital Management reported 31 positions worth $4.71B in its Q3 2026 13F filing. Largest positions: CVE (9.0%), MRK (7.1%), APA (6.8%), MAC (5.4%) and SPG (5.4%).
What did Smead Capital Management buy in Q3 2026?
Added to: CROX, ZTS, WAL, LEN and FRO (9 in all).
What did Smead Capital Management sell in Q3 2026?
Reduced: AMGN, SPG, TGT, BAC and MRK (22 in all). Sold out entirely: OXY-WS.
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.